Glynib (Imatinib) Capsules 100mg are highly effective targeted cancer medicines used worldwide for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Glynib (Imatinib) Capsules 100mg belong to the class of tyrosine kinase inhibitors, a modern category of cancer treatment medicines designed to block abnormal proteins that trigger uncontrolled cancer cell growth.
Imatinib 100mg capsules work by specifically targeting cancer-causing enzymes, helping stop the spread of cancer cells while protecting healthy tissue. This targeted action makes Imatinib Capsules 100mg one of the most trusted options for long-term CML treatment and GIST treatment under specialist medical supervision. Oncologists frequently recommend Glynib (Imatinib) Capsules 100mg for patients with Philadelphia chromosome-positive chronic myeloid leukemia, including early, accelerated, and advanced phases of the disease.
In addition to leukemia care, Glynib (Imatinib) Capsules 100mg are also prescribed for gastrointestinal stromal tumors (GIST), where Imatinib 100mg helps reduce tumor growth, control disease progression, and lower the risk of recurrence after surgery. Continuous therapy with Imatinib Capsules has been shown to improve survival rates and enhance overall quality of life for cancer patients.
As a trusted oral cancer medicine, Glynib (Imatinib) Capsules 100mg offer the convenience of capsule dosing, making long-term cancer treatment more manageable. Patients using Imatinib 100mg capsules should follow their oncologist’s instructions carefully and undergo regular monitoring to ensure safety and maximum therapeutic benefit.
Available through licensed online pharmacies, Glynib (Imatinib) Capsules 100mg provide a reliable, effective, and targeted solution for patients seeking genuine Imatinib cancer treatment for CML and GIST.
Uses
Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an antineoplastic (cancer) agent. Imatinib is used for these conditions:
Aggressive systemic mastocytosis (ASM)
Chronic eosinophilic leukemia (CEL)
Dermatofibrosarcoma protuberans (DFSP)
Gastrointestinal stromal tumors (GIST)
Hypereosinophilic syndrome (HES)
Myelodysplastic syndrome (MDS)
Myeloproliferative diseases (MPD)
Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML)
Dosage
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
For oral dosage form (tablets):
For the treatment of aggressive systemic mastocytosis (ASM):
Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed.
Children—Use and dose must be determined by your doctor.
For the treatment of chronic eosinophilic leukemia (CEL) or hypereosinophilic syndrome (HES):
Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed.
Children—Use and dose must be determined by your doctor.
For the treatment of dermatofibrosarcoma protuberans (DFSP):
Adults—800 milligrams (mg) per day as a single dose or divided and given as 400 mg 2 times per day.
Children—Use and dose must be determined by your doctor.
For the treatment of gastrointestinal stromal tumors (GIST):
Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 800 mg per day.
Children—Use and dose must be determined by your doctor.
For the treatment of myelodysplastic syndrome (MDS) or myeloproliferative diseases (MPD):
Adults—400 milligrams (mg) once a day.
Children—Use and dose must be determined by your doctor.
For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL):
Adults—600 milligrams (mg) once a day.
Children 1 year of age and older—Dose is based on body size and must be determined by your doctor. The dose is usually 340 milligrams per square meter (mg/m[2]) per day. The dose may be taken once a day or the dose may be divided into two small doses (once in the morning and once in the evening). However, the dose is usually not more than 600 mg per day.
Children younger than 1 year of age—Use and dose must be determined by your doctor.
For the treatment of accelerated phase or blast crisis Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML):
Adults—600 milligrams (mg) once a day.
Children 1 year of age and older—Dose is based on body size and must be determined by your doctor. The dose is usually 340 milligrams per square meter (mg/m[2]) per day. The dose may be taken once a day or the dose may be divided into two small doses (once in the morning and once in the evening). However, the dose is usually not more than 600 mg per day.
Children younger than 1 year of age—Use and dose must be determined by your doctor.
For the treatment of chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML):
Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 800 mg per day.
Children 1 year of age and older—Dose is based on body size and must be determined by your doctor. The dose is usually 340 milligrams per square meter (mg/m[2]) per day. The dose may be taken once a day or divided into 2 small doses (once in the morning and once in the evening). However, the dose is usually not more than 600 mg per day.
Children younger than 1 year of age—Use and dose must be determined by your doctor.
Warnings and Precautions
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of imatinib to treat Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and acute lymphoblastic leukemia (Ph+ ALL) in children younger than 1 year of age and to treat other conditions in children. Safety and efficacy have not been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of imatinib in the elderly. However, serious side effects (eg, swelling of the face, hands, fingers, feet, or lower legs, and unusual weight gain) may be more likely to occur in elderly patients, who may be more sensitive than younger adults to the effects of imatinib.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Using this medicine while you are pregnant can harm your unborn baby. If you can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. Use a highly effective form of birth control to keep from getting pregnant during treatment and for 14 days after your last dose of this medicine. If you think you have become pregnant while using the medicine, tell your doctor right away.
Serious skin reactions, including erythema multiforme and Stevens-Johnson syndrome can occur during treatment with this medicine. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, red skin lesions, severe acne or skin rash, sores or ulcers on the skin, or fever or chills while you are using this medicine.
Some serious side effects including black, tarry stools, severe stomach pain, or vomiting of blood or material that looks like coffee grounds can occur during treatment with this medicine.
While you are being treated with imatinib, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Imatinib may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have recently taken oral polio vaccine. Do not get close to them and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.
Imatinib can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
Check with your doctor immediately if you notice any unusual bleeding or bruising, black, tarry stools, blood in the urine or stools, or pinpoint red spots on your skin.
Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
Avoid contact sports or other situations where bruising or injury could occur.
This medicine may cause slowed growth and development in children. Your child's doctor may want to monitor their weight and growth regularly. Talk to your child's doctor if you have concerns.
This medicine may cause a serious type of reaction called tumor lysis syndrome. Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.
